Trial Utilizing Metronidazole to Optimize the Microbiome of Rectal Adenocarcinoma Undergoing Neoadjuvant Therapy
Clinical trial NCT06569368 · RECRUITING
Trial details
- NCT number
- NCT06569368
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-10
- Primary completion
- 2027-10-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.